Management of primary Sjögren's syndrome: recent developments and new classification criteria

N Del Papa, C Vitali - Therapeutic advances in …, 2018 - journals.sagepub.com
For many years primary Sjögren's syndrome (pSS) has been considered an orphan disease,
since no specific therapies were recognized as being capable of contrasting the …

Emerging drugs for primary Sjögren's syndrome

S Gandolfo, S De Vita - Expert Opinion on Emerging Drugs, 2019 - Taylor & Francis
ABSTRACT Introduction: Primary Sjögren's syndrome (pSS) is an autoimmune systemic
disease characterized by a complex and not yet completely elucidated etiopathogenesis …

Management of Sjögren's syndrome: present issues and future perspectives

C Vitali, A Minniti, F Pignataro, W Maglione… - Frontiers in …, 2021 - frontiersin.org
In view of the new possibilities for the treatment of primary Sjögren's syndrome (pSS) given
by the availability of new biotechnological agents targeting the various molecular and …

An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development

S Retamozo, A Sisó-Almirall… - Expert Opinion on …, 2021 - Taylor & Francis
ABSTRACT Introduction: Primary Sjögren syndrome (pSS) is a systemic autoimmune
disease that may affect 3 in 1,000 people within the general population. The therapeutic …

Current and future therapies for primary Sjögren syndrome

R Seror, G Nocturne, X Mariette - Nature Reviews Rheumatology, 2021 - nature.com
Primary Sjögren syndrome (pSS) is a systemic autoimmune disease that is characterized by
a triad of symptoms that affect all patients (dryness, pain and fatigue). In addition, systemic …

Present and future of biologic drugs in primary Sjögren's syndrome

D Sambataro, G Sambataro, Y Dal Bosco… - Expert Opinion on …, 2017 - Taylor & Francis
ABSTRACT Introduction: Primary Sjögren's (pSS) syndrome is a chronic, autoimmune, and
systemic disease characterized by xerostomia, xerophthalmia, muscle pain and fatigue. The …

Treating Sjögren's syndrome: insights for the clinician

C Vitali, G Palombi, P Cataleta - Therapeutic Advances in …, 2010 - journals.sagepub.com
Sjögren's syndrome (SS) is a systemic autoimmune disease that affects the exocrine glands,
mainly the salivary and lachrymal glands, with consequent persistent dryness of the mouth …

Treating the underlying pathophysiology of primary Sjögren syndrome: recent advances and future prospects

P Brito-Zerón, S Retamozo, H Gheitasi… - Drugs, 2016 - Springer
Sjögren Syndrome (SS) is a systemic autoimmune disease with a wide clinical spectrum that
extends from sicca symptoms of the mucosal surfaces to extra-glandular systemic …

Treatment of primary Sjögren syndrome

A Saraux, JO Pers… - Nature Reviews …, 2016 - nature.com
Primary Sjögren syndrome (pSS) is a progressive autoimmune disease characterized by
sicca and systemic manifestations. In this Review, we summarize the available data on …

Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions

P Brito-Zerón, A Sisó-Almirall, A Bové… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Primary Sjögren syndrome (SS) is a chronic systemic autoimmune disease
characterized by sicca features and systemic manifestations, and requires a multidisciplinary …